InsidersTradesSigma
Total declarations
Companies
▲ Purchases (1 ops.)
▼ Sales (2 ops.)
Insider track record
Board DirectorDisclosed buys
1
Disclosed sells
2
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Discover the full record of transactions filed by Dietz Thomas John, Director. Officer active across 3 companies, notably Paratek Pharmaceuticals, Inc.. Cumulatively, 9 reports have been published. Split: 1 buy · 2 sells. Total volume traded: €120k. History available since 16 February 2022. The latest transaction was disclosed on 26 August 2026 (Cession). Regulator: SEC (Form 4). All data is accessible without signup.
Companies and markets linked to Dietz Thomas John
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations9 total
20,000 shares@ US$1.72Common StockSEC:0001104659-26-102467:0
104,500 sharesCommon StockSEC:0001104659-26-029646:0
83,000 sharesCommon StockSEC:0001104659-25-125256:0
49,250 sharesCommon StockSEC:0000899243-23-019349:0
20,000 shares0Common StockSEC:0000904454-23-000101:0
50,000 shares@ US$1.431672.7% of flowCommon StockSEC:0001567619-23-001284:0
Canonical exit: 23 Apr 2023 (T+90)
22,500 shares@ US$1.16927.3% of flowCommon StockSEC:0001140361-22-047071:0
6,000 shares0Common StockSEC:0001140361-22-009257:0
20,000 shares0Common StockSEC:0000904454-22-000163:0
9 of 9 declarations
About Dietz Thomas John
Dietz Thomas John is Administrateur and has filed 8 disclosures in total. Across the 8 recent filings we hold, the period runs from 2022-02-18 to 2026-03-17, with EUR 65881 of buys and EUR 24790 of sells, mainly at Eiger BioPharmaceuticals, Inc., as well as filings at Paratek Pharmaceuticals, Inc. and CYPHERPUNK TECHNOLOGIES INC.
